Global GI Oncology Data Gen Lead – Real-World Evidence

GlaxoSmithKline

Upper Providence (Delaware County)

Hybride

USD 227 000 - 378 000

Plein temps

Il y a 11 jours

Obtenez une réponse de cet employeur

Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.

Passez les filtres ATS

Avantages offerts par ce poste

Health insurance
Retirement benefits
Paid holidays
Vacation
Parental leave

Résumé du poste

GlaxoSmithKline is seeking a Global Data Generation GI Oncology Franchise Head to oversee Data Generation for the oncology portfolio, delivering real-world evidence and non-interventional studies across the product lifecycle. You will design evidence generation plans and collaborate with Medical Affairs, Clinical Development, Market Access, Commercial, and external partners.

This role requires advanced degrees and substantial experience in health outcomes, with leadership of cross-functional

Qualifications

  • Advanced degree in health outcomes, health economics, epidemiology, biostatistics, clinical research, pharmacy, medicine, or related discipline.
  • 7+ years of experience in health outcomes, real-world evidence, health economics, or related functions within pharma or healthcare.
  • Hands-on experience with observational study design, comparative effectiveness, economic modeling, or advanced analytical methods.
  • Experience designing evidence generation plans to support commercialization, reimbursement, market access or regulatory submissions.
  • A track record of scientific publications or presentations at major congresses.
  • Experience leading cross-functional teams and influencing stakeholders across clinical, medical, commercial and access functions.
  • Strong project management skills with experience managing multiple studies and external partners.
  • Experience in direct line management.
  • Excellent written and verbal communication skills with the ability to present complex evidence clearly to diverse audiences.

Responsabilités

  • Work in partnership with the Global Medical Franchise Head to develop the overall data generation plans that align clinical, regulatory and access needs across the product lifecycle for all assets in the franchise.
  • Oversee integrated evidence generation across all assets in the franchise and lead evidence generation for the flagship asset while providing strategic direction and oversight for other assets within the franchise.
  • Oversee delivery of non-interventional studies, including protocol development, study execution,analysisand transparent reporting.
  • Lead and mentor the Data Generation team responsible for real-world evidence including health economic studies and outcomes research.
  • Partner with clinical development and medical teams to shape study design,endpointsand comparators to meetpayerand HTA expectations.
  • Represent the team in cross-functional governance and in external scientific dialogue with payers, HTA bodies and academic partners.
  • Manage resource planning and budget for all evidence activities and trackimpactof evidence on internal decision-making and external access outcomes.

Connaissances

Cross-Functional Leadership
Digital Fluency
Enterprise Thinking
Evidence Based Decision Making
Flexible Mindset
High Impact Communication
Launch Excellence
Patient Journey
Project Management

Formation

PhD/PharmD/Master in health outcomes

Description du poste

GlaxoSmithKline is seeking a Global Data Generation GI Oncology Franchise Head to oversee Data Generation for the oncology portfolio, delivering real-world evidence and non-interventional studies across the product lifecycle. You will design evidence generation plans and collaborate with Medical Affairs, Clinical Development, Market Access, Commercial, and external partners.

This role requires advanced degrees and substantial experience in health outcomes, with leadership of cross-functional

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Global GI Oncology Data Gen Lead — Real-World Evidence
Global GI Oncology Data Gen Lead — Real-World Evidence

GlaxoSmithKline • États-Unis

Hybride
USD 227 000 - 378 000
Health care
Retirement benefits
Paid holidays
+1
Hybrid Global GI Oncology Data & Evidence Lead
Hybrid Global GI Oncology Data & Evidence Lead

GSK plc • Pennsylvania

Hybride
USD 227 000 - 378 000
Health care benefits
Retirement benefits
Paid holidays
+2
GI Oncology Data Generation Lead — RWE Strategy
GI Oncology Data Generation Lead — RWE Strategy

GSK • Upper Providence

Hybride
USD 227 000 - 378 000
Health care benefits
Retirement benefits
Paid holidays
+1
Global Data Generation GI Oncology Franchise Head
Global Data Generation GI Oncology Franchise Head

GlaxoSmithKline • Upper Providence

Hybride
USD 227 000 - 378 000
Health insurance
Retirement benefits
Paid holidays
+2
Global Data Generation GI Oncology Franchise Head
Global Data Generation GI Oncology Franchise Head

GlaxoSmithKline • États-Unis

Hybride
USD 227 000 - 378 000
Health care
Retirement benefits
Paid holidays
+1
Global Real-World Evidence Lead, Oncology & Outcomes
Global Real-World Evidence Lead, Oncology & Outcomes

GlaxoSmithKline • Upper Providence

Hybride
USD 204 000 - 340 000
Annual bonus
Healthcare programs
Pension plan
+2
Global Data Generation GI Oncology Franchise Head
Global Data Generation GI Oncology Franchise Head

GSK plc • Pennsylvania

Hybride
USD 227 000 - 378 000
Health care benefits
Retirement benefits
Paid holidays
+2
Director, Oncology Real-World Evidence & Outcomes
Director, Oncology Real-World Evidence & Outcomes

GSK • Rockville (MD)

Hybride
USD 204 000 - 340 000
Annual bonus
Healthcare
Pension plan
+2
Global Director, Oncology Evidence Generation
Global Director, Oncology Evidence Generation

Bristol Myers Squibb • Madison (NJ)

Hybride
USD 207 000 - 251 000
Director, Global Real-World Evidence & Oncology Outcomes - Remote
Director, Global Real-World Evidence & Oncology Outcomes - Remote

GSK • États-Unis

Hybride
USD 204 000 - 340 000
Annual bonus
Shares and savings programme
Healthcare and wellbeing programs
+1